Dana Gabuzda
Overview
Explore the profile of Dana Gabuzda including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
106
Citations
4684
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ament S, Campbell R, Lobo M, Receveur J, Agrawal K, Borjabad A, et al.
Mol Psychiatry
. 2024 Jun;
29(12):3950-3961.
PMID: 38879719
Substance use disorders (SUD) and drug addiction are major threats to public health, impacting not only the millions of individuals struggling with SUD, but also surrounding families and communities. One...
2.
Guha D, Misra V, Chettimada S, Yin J, Gabuzda D
Viruses
. 2024 Jan;
16(1).
PMID: 38257772
HIV-associated neurocognitive disorders (HAND) remain prevalent despite viral suppression on antiretroviral therapy (ART). Older people with HIV (PWH) are also at risk for amnestic mild cognitive impairment (aMCI) and Alzheimer's...
3.
Guha D, Misra V, Yin J, Gabuzda D
Viruses
. 2023 Sep;
15(9).
PMID: 37766236
HIV establishes a viral reservoir in the CNS despite viral suppression in the blood on antiretroviral therapy (ART). In a minority of people with HIV (PWH), HIV RNA is detectable...
4.
Guha D, Misra V, Yin J, Horiguchi M, Uno H, Gabuzda D
medRxiv
. 2023 Aug;
PMID: 37546734
Objective: Human immunodeficiency virus (HIV)-associated neurocognitive disorders (HAND) remain prevalent despite viral suppression on antiretroviral therapy (ART). Vascular disease contributes to HAND, but peripheral markers that distinguish vascular cognitive impairment...
5.
Guha D, Misra V, Yin J, Horiguchi M, Uno H, Gabuzda D
AIDS
. 2023 Jul;
37(14):2137-2147.
PMID: 37503603
Objective: Human immunodeficiency virus (HIV)-associated neurocognitive disorders (HAND) remain prevalent despite viral suppression on antiretroviral therapy (ART). Vascular disease contributes to HAND, but peripheral markers that distinguish vascular cognitive impairment...
6.
Gabuzda D, Yin J, Misra V, Chettimada S, Gelman B
Viruses
. 2023 Apr;
15(4).
PMID: 37112989
HIV establishes a persistent viral reservoir in the brain despite viral suppression in blood to undetectable levels on antiretroviral therapy (ART). The brain viral reservoir in virally suppressed HIV+ individuals...
7.
Mukerji S, Petersen K, Pohl K, Dastgheyb R, Fox H, Bilder R, et al.
J Infect Dis
. 2023 Mar;
227(Suppl 1):S48-S57.
PMID: 36930638
Cognitive disorders are prevalent in people with HIV (PWH) despite antiretroviral therapy. Given the heterogeneity of cognitive disorders in PWH in the current era and evidence that these disorders have...
8.
Spatola M, Loos C, Cizmeci D, Webb N, Gorman M, Rossignol E, et al.
J Infect Dis
. 2022 Apr;
226(4):738-750.
PMID: 35417540
The central nervous system (CNS) has emerged as a critical HIV reservoir. Thus, interventions aimed at controlling and eliminating HIV must include CNS-targeted strategies. Given the inaccessibility of the brain,...
9.
Lorenz D, Mukerji S, Misra V, Uno H, Gelman B, Moore D, et al.
J Acquir Immune Defic Syndr
. 2021 Nov;
88(5):518-527.
PMID: 34757975
Background: People with HIV (PWH) have increased frailty risk at younger ages compared with the general population. Multimorbidity is associated with frailty, yet effects of specific comorbidities on transition to...
10.
Lorenz D, Mukerji S, Misra V, Uno H, Gelman B, Moore D, et al.
AIDS
. 2021 Jul;
35(15):2451-2461.
PMID: 34324449
Objective: People with HIV (PWH) have increased prevalence of multimorbidity and frailty at younger ages compared with the general population. This study investigated individual and combinatorial effects of neuropsychiatric and...